Comparative Bioinformatics Characteristic of Bladder Cancer Stage 2 from Stage 4 Expression Profile: A Network-Based Study
Bladder cancer (BC) has remained as one of the most challenging issues in medicine. The aim of this study was to investigate the differential network analysis of stages 2 and 4 of BC to better understand the molecular pathology of these states. We chose gene expression data of GSE52519 from Gene Exp...
Saved in:
| Published in | Galen Vol. 7; p. e1279 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
Iran
Salvia Medical Sciences Ltd
01.01.2018
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 2322-2379 2588-2767 2322-2379 |
| DOI | 10.22086/gmj.v0i0.1279 |
Cover
| Abstract | Bladder cancer (BC) has remained as one of the most challenging issues in medicine. The aim of this study was to investigate the differential network analysis of stages 2 and 4 of BC to better understand the molecular pathology of these states.
We chose gene expression data of GSE52519 from Gene Expression Omnibus (GEO) database analyzed by the GEO2R online tool. Cytoscape version 3.6.1 and its algorithms are the methods applied for the network construction and investigation of differentially expressed genes (DEG) in these states.
Our result revealed that the analysis DEGs provides useful information about a common molecular feature of stages 2 and 4 of BC.
Consequently, the network finding revealed that more investigation about stage 2 is required to achieve an effective therapeutic protocol to block the transition from stage 2 to stage 4. |
|---|---|
| AbstractList | Bladder cancer (BC) has remained as one of the most challenging issues in medicine. The aim of this study was to investigate the differential network analysis of stages 2 and 4 of BC to better understand the molecular pathology of these states.BACKGROUNDBladder cancer (BC) has remained as one of the most challenging issues in medicine. The aim of this study was to investigate the differential network analysis of stages 2 and 4 of BC to better understand the molecular pathology of these states.We chose gene expression data of GSE52519 from Gene Expression Omnibus (GEO) database analyzed by the GEO2R online tool. Cytoscape version 3.6.1 and its algorithms are the methods applied for the network construction and investigation of differentially expressed genes (DEG) in these states.MATERIALS AND METHODSWe chose gene expression data of GSE52519 from Gene Expression Omnibus (GEO) database analyzed by the GEO2R online tool. Cytoscape version 3.6.1 and its algorithms are the methods applied for the network construction and investigation of differentially expressed genes (DEG) in these states.Our result revealed that the analysis DEGs provides useful information about a common molecular feature of stages 2 and 4 of BC.RESULTOur result revealed that the analysis DEGs provides useful information about a common molecular feature of stages 2 and 4 of BC.Consequently, the network finding revealed that more investigation about stage 2 is required to achieve an effective therapeutic protocol to block the transition from stage 2 to stage 4.CONCLUSIONConsequently, the network finding revealed that more investigation about stage 2 is required to achieve an effective therapeutic protocol to block the transition from stage 2 to stage 4. Bladder cancer (BC) has remained as one of the most challenging issues in medicine. The aim of this study was to investigate the differential network analysis of stages 2 and 4 of BC to better understand the molecular pathology of these states. We chose gene expression data of GSE52519 from Gene Expression Omnibus (GEO) database analyzed by the GEO2R online tool. Cytoscape version 3.6.1 and its algorithms are the methods applied for the network construction and investigation of differentially expressed genes (DEG) in these states. Our result revealed that the analysis DEGs provides useful information about a common molecular feature of stages 2 and 4 of BC. Consequently, the network finding revealed that more investigation about stage 2 is required to achieve an effective therapeutic protocol to block the transition from stage 2 to stage 4. |
| Author | Rezaei-Tavirani, Majid Zamanian Azodi, Mona Rezaei Tavirani, Mostafa Rostami-Nejad, Mohammad |
| AuthorAffiliation | 1 Student Research Committee, Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran 2 Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran 4 Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran 3 Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran |
| AuthorAffiliation_xml | – name: 4 Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran – name: 3 Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran – name: 1 Student Research Committee, Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran – name: 2 Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran |
| Author_xml | – sequence: 1 givenname: Mona surname: Zamanian Azodi fullname: Zamanian Azodi, Mona organization: Student Research Committee, Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran – sequence: 2 givenname: Mostafa surname: Rezaei Tavirani fullname: Rezaei Tavirani, Mostafa organization: Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran – sequence: 3 givenname: Mohammad surname: Rostami-Nejad fullname: Rostami-Nejad, Mohammad organization: Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran – sequence: 4 givenname: Majid surname: Rezaei-Tavirani fullname: Rezaei-Tavirani, Majid organization: Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34466446$$D View this record in MEDLINE/PubMed |
| BookMark | eNpVUMFO3DAUtNAiFihXjsjHXrJ1_GLH6aESG0FbCQFS6TlykufF2yRO7ey28PUYdUHbw9O8eTOakd4JmQ1uQELOU7bgnCn5adWvF1tm2SLleXFAjjlwnnDIi9nePidnIawZY2kKAFIckTlkmZRxjslz6fpRez3ZLdKldXYwzveRNoGWj1FoJvQ2RE6doctOty16WuqhifBj0iuknBrv-h3J6NXf0WMI1g303jtjO_xML-ktTn-c_5UsdcA2ejft0wdyaHQX8GyHp-Tn9dVD-S25ufv6vby8Sca0kFOiVY21AW1YWigZ67OMKaNEniswWWoEsKx-PRcCgIMAgRJBS163shCpgVPy5V_uuKl7bBscJq-7avS21_6pctpW_yuDfaxWblspyCBXPAZ83AV493uDYap6GxrsOj2g24SKC6m4YAWDaL3Y73oveXs4vAD1C4ch |
| ContentType | Journal Article |
| Copyright | Copyright© 2018, Galen Medical Journal. Copyright© 2018, Galen Medical Journal. 2018 |
| Copyright_xml | – notice: Copyright© 2018, Galen Medical Journal. – notice: Copyright© 2018, Galen Medical Journal. 2018 |
| DBID | NPM 7X8 5PM |
| DOI | 10.22086/gmj.v0i0.1279 |
| DatabaseName | PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2322-2379 |
| EndPage | e1279 |
| ExternalDocumentID | PMC8343782 34466446 |
| Genre | Journal Article |
| GroupedDBID | ALMA_UNASSIGNED_HOLDINGS M~E NPM OK1 RNS RPM 7X8 5PM |
| ID | FETCH-LOGICAL-p196t-a8bebf3af01986dde4408f857783f41f5304bdde4953323535e6e3a62bd6951f3 |
| ISSN | 2322-2379 2588-2767 |
| IngestDate | Thu Aug 21 13:47:22 EDT 2025 Wed Oct 01 14:38:20 EDT 2025 Thu Jan 02 22:39:46 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Biomarkers Bladder Neoplasm Transcriptome Protein Interaction Maps |
| Language | English |
| License | Copyright© 2018, Galen Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/) |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-p196t-a8bebf3af01986dde4408f857783f41f5304bdde4953323535e6e3a62bd6951f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC8343782 |
| PMID | 34466446 |
| PQID | 2568250903 |
| PQPubID | 23479 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8343782 proquest_miscellaneous_2568250903 pubmed_primary_34466446 |
| PublicationCentury | 2000 |
| PublicationDate | 2018-01-01 |
| PublicationDateYYYYMMDD | 2018-01-01 |
| PublicationDate_xml | – month: 01 year: 2018 text: 2018-01-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Iran |
| PublicationPlace_xml | – name: Iran |
| PublicationTitle | Galen |
| PublicationTitleAlternate | Galen Med J |
| PublicationYear | 2018 |
| Publisher | Salvia Medical Sciences Ltd |
| Publisher_xml | – name: Salvia Medical Sciences Ltd |
| SSID | ssj0001133365 |
| Score | 2.030892 |
| Snippet | Bladder cancer (BC) has remained as one of the most challenging issues in medicine. The aim of this study was to investigate the differential network analysis... |
| SourceID | pubmedcentral proquest pubmed |
| SourceType | Open Access Repository Aggregation Database Index Database |
| StartPage | e1279 |
| SubjectTerms | Original |
| Title | Comparative Bioinformatics Characteristic of Bladder Cancer Stage 2 from Stage 4 Expression Profile: A Network-Based Study |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/34466446 https://www.proquest.com/docview/2568250903 https://pubmed.ncbi.nlm.nih.gov/PMC8343782 |
| Volume | 7 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2322-2379 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001133365 issn: 2322-2379 databaseCode: RPM dateStart: 20180101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9owELboVqp6qfru9iVXqnpZmRo7DqE3QLtdVQuVKpBQL5FNnF1QSSiFHvgT_cudsb2QrDhseyDCdmRHnk_j8XjmMyHvE2F4prViXMeKRUrHzMBKwMwUvW42anGL-c6DYXw-jr5M1KTR-FOJWtqsTXO6PZhX8j9ShTqQK2bJ_oNkd51CBfwH-cITJAzPW8m4X6Hu7s3KQILqiJf7NSJmNAl7P1DJrE76KOcVWpmX6Hx1-SW-ECHxsY-LLTCDwHE2ucz1oQ8WZz1Y8zIXe1g7Df4Mq8wOZN81UmqA2uhuy8zFCoDe2Cn_b3ar7exkpDG4uAjNYKHm-zewuJixoZ17-A3KK71Y6KzeBat1oechMj84MFpJxYHh9JzA_bCQ_k6Zpj1QFxR1u6JobUv4xptLgBDcHUldLubN33yG9BnXPVe5todf07PxxUU6Op2MPix_MryGDI_rw50sd8hdAcsEr7h_nNMOdvTSXU-6-0BPBOpG_Vgb89CW5WbkbcWUGT0kD8IehHY9oB6Rhi0ek3uDEGXxhGwruKJ1XNE6rmiZ04Ar6nFFHZSooIirUIjoHlc04OoT7dIaqqhD1VMyPjsd9c9ZuKODLUF3r5lOjDW51DlsFZIYhsMbzPNEtduJzKNWriSPDFZjGLOQSiobW6ljYbIYjPtcPiNHRVnYF4QmIs9aqm2NSPIo5tpoNc244jrrSN2J5DF5dz2hKehAPNjShS03v1Iw2xMw5Tsc3nnuJzhderKWVGLAAvyOSbs29bsXkF-93lLMrhzPeiIjCQb0y1uM-4rc30P7NTlarzb2DVira_PWIegvVgicXw |
| linkProvider | National Library of Medicine |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparative+Bioinformatics+Characteristic+of+Bladder+Cancer+Stage+2+from+Stage+4+Expression+Profile%3A+A+Network-Based+Study&rft.jtitle=Galen&rft.au=Zamanian+Azodi%2C+Mona&rft.au=Rezaei+Tavirani%2C+Mostafa&rft.au=Rostami-Nejad%2C+Mohammad&rft.au=Rezaei-Tavirani%2C+Majid&rft.date=2018-01-01&rft.issn=2322-2379&rft.eissn=2322-2379&rft.volume=7&rft.spage=e1279&rft_id=info:doi/10.22086%2Fgmj.v0i0.1279&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2322-2379&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2322-2379&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2322-2379&client=summon |